JPWO2021054420A1 - - Google Patents

Info

Publication number
JPWO2021054420A1
JPWO2021054420A1 JP2021546964A JP2021546964A JPWO2021054420A1 JP WO2021054420 A1 JPWO2021054420 A1 JP WO2021054420A1 JP 2021546964 A JP2021546964 A JP 2021546964A JP 2021546964 A JP2021546964 A JP 2021546964A JP WO2021054420 A1 JPWO2021054420 A1 JP WO2021054420A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021546964A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021054420A1 publication Critical patent/JPWO2021054420A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Manufacturing & Machinery (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2021546964A 2019-09-20 2020-09-18 Pending JPWO2021054420A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019171135 2019-09-20
PCT/JP2020/035375 WO2021054420A1 (en) 2019-09-20 2020-09-18 Sugar chain-presenting particles and production method thereof

Publications (1)

Publication Number Publication Date
JPWO2021054420A1 true JPWO2021054420A1 (en) 2021-03-25

Family

ID=74884074

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021546964A Pending JPWO2021054420A1 (en) 2019-09-20 2020-09-18

Country Status (2)

Country Link
JP (1) JPWO2021054420A1 (en)
WO (1) WO2021054420A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007018273A1 (en) * 2005-08-11 2007-02-15 National Institute Of Advanced Industrial Science And Technology Composition for delivering diagnostic agent containing sugar-modified liposome
WO2007089043A1 (en) * 2006-02-03 2007-08-09 Takeda Pharmaceutical Company Limited Liposome preparation
JPWO2009148169A1 (en) * 2008-06-06 2011-11-04 片山化学工業株式会社 Tumor therapy using liposomes encapsulating ammine platinum complex at high concentration
EP3409772B1 (en) * 2016-01-29 2023-06-28 National University Corporation Hokkaido University Intracellular substance transport system and use thereof
JPWO2019208820A1 (en) * 2018-04-27 2021-06-24 国立大学法人北海道大学 Intracellular substance transfer system and its use

Also Published As

Publication number Publication date
WO2021054420A1 (en) 2021-03-25

Similar Documents

Publication Publication Date Title
BR112019017762A2 (en)
BR112021013854A2 (en)
BR112021018450A2 (en)
BR112019016141A2 (en)
AU2020104490A4 (en)
BR112019016142A2 (en)
BR112019016138A2 (en)
BR112021018168A2 (en)
BR112021008711A2 (en)
BR112021017355A2 (en)
BR112021017173A2 (en)
BR112021018102A2 (en)
BR112021017083A2 (en)
BR112021018452A2 (en)
BR112021012348A2 (en)
BR112021018250A2 (en)
BR112021018093A2 (en)
BR112021018084A2 (en)
BR112021013944A2 (en)
BR112021013128A2 (en)
BR112021018484A2 (en)
BR112021015080A2 (en)
BR112021017983A2 (en)
BR112021016205A2 (en)
BR112021016996A2 (en)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230720